• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金纳米颗粒在BBN诱导的小鼠肌肉浸润性膀胱癌中的生物分布。

Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.

作者信息

Smilowitz Henry M, Tarmu Lauren J, Sanders Mary Melinda, Taylor John A, Choudhary Dharamainder, Xue Crystal, Dyment Nathaniel A, Sasso Dan, Deng Xiaomeng, Hainfeld James F

机构信息

Department of Cell Biology, University of Connecticut Health Center, Farmington, CT.

Department of Human Behavior, College of Southern Nevada, North Las Vegas.

出版信息

Int J Nanomedicine. 2017 Oct 27;12:7937-7946. doi: 10.2147/IJN.S140977. eCollection 2017.

DOI:10.2147/IJN.S140977
PMID:29138560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667800/
Abstract

Bladder-sparing options are being developed for muscle-invasive bladder cancer in place of radical cystectomy, including the combination of chemotherapy and radiation therapy. We reasoned that improving the radiotherapy component of chemoradiation could improve the control of locally advanced disease. Previously, we showed that gold nanoparticles (AuNPs) are potent enhancers of radiation therapy. We hypothesized that if AuNPs were to preferentially localize to bladder tumors, they may be used to enhance the radiation component of muscle-invasive bladder tumor therapy. Mice were treated with the carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 17, 20, and 22 weeks - long enough to induce muscle-invasive tumors. Mice were then anesthetized and injected intravenously with 1.9 nm AuNPs of which most were rapidly cleared from the blood and excreted after a 30-50 minute residence time in the bladder. We found AuNPs distributed throughout the bladder wall, but most of the AuNPs were associated with the stroma surrounding the tumor cells or extracellular keratin produced by the tumor cells. There were relatively few AuNPs in the tumor cells themselves. The AuNPs therefore localized to tumor-associated stroma and this tumor specificity might be useful for specific X-ray dose enhancement therapy of muscle-invasive bladder carcinomas.

摘要

正在开发用于肌肉浸润性膀胱癌的保留膀胱方案,以替代根治性膀胱切除术,包括化疗和放射治疗的联合应用。我们推断,改善放化疗中的放疗部分可能会改善局部晚期疾病的控制。此前,我们表明金纳米颗粒(AuNPs)是放射治疗的有效增强剂。我们假设,如果AuNPs能优先定位于膀胱肿瘤,它们可能会被用于增强肌肉浸润性膀胱肿瘤治疗的放疗部分。用致癌物N-丁基-N-(4-羟基丁基)亚硝胺(BBN)对小鼠进行17、20和22周的处理——时间足够长以诱导肌肉浸润性肿瘤。然后将小鼠麻醉并静脉注射1.9 nm的AuNPs,其中大部分在血液中迅速清除,并在膀胱中停留30 - 50分钟后排出。我们发现AuNPs分布于整个膀胱壁,但大多数AuNPs与肿瘤细胞周围的基质或肿瘤细胞产生的细胞外角蛋白相关。肿瘤细胞本身中的AuNPs相对较少。因此,AuNPs定位于肿瘤相关基质,这种肿瘤特异性可能对肌肉浸润性膀胱癌的特异性X射线剂量增强治疗有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/a82a1f3cfa38/ijn-12-7937Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/23c78b5f465d/ijn-12-7937Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/59da29e94ec1/ijn-12-7937Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/e31b16086e60/ijn-12-7937Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/c9ad410386c9/ijn-12-7937Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/a0f3f31c7b92/ijn-12-7937Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/25b36b263b0b/ijn-12-7937Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/a82a1f3cfa38/ijn-12-7937Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/23c78b5f465d/ijn-12-7937Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/59da29e94ec1/ijn-12-7937Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/e31b16086e60/ijn-12-7937Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/c9ad410386c9/ijn-12-7937Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/a0f3f31c7b92/ijn-12-7937Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/25b36b263b0b/ijn-12-7937Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d7/5667800/a82a1f3cfa38/ijn-12-7937Fig7.jpg

相似文献

1
Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.金纳米颗粒在BBN诱导的小鼠肌肉浸润性膀胱癌中的生物分布。
Int J Nanomedicine. 2017 Oct 27;12:7937-7946. doi: 10.2147/IJN.S140977. eCollection 2017.
2
High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.p53(+/-)基因敲除小鼠在N-丁基-N-(4-羟丁基)亚硝胺诱导的膀胱癌发生过程中具有高度易感性,且残留等位基因中无频繁突变。
Cancer Res. 1998 Sep 1;58(17):3806-11.
3
Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.谷胱甘肽S-转移酶M1蛋白在N-丁基-N-(4-羟丁基)亚硝胺诱导的小鼠膀胱癌发生过程中的表达下调
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):322-330. doi: 10.1016/j.taap.2014.06.018. Epub 2014 Jul 3.
4
Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.N-丁基-N-(4-羟丁基)亚硝胺的组织特异性诱变作为尿路上皮癌发生的基础。
Mutat Res. 2012 Feb 18;742(1-2):92-5. doi: 10.1016/j.mrgentox.2011.11.015. Epub 2011 Dec 4.
5
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.塞来昔布可抑制雄性B6D2F1小鼠和雌性Fischer-344大鼠中由N-丁基-N-(4-羟基丁基)-亚硝胺诱导的膀胱癌。
Cancer Res. 2000 Oct 15;60(20):5599-602.
6
Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.关于环磷酰胺的作用,N-丁基-N-(4-羟丁基)亚硝胺和N-乙基-N-(4-羟丁基)亚硝胺诱导的小鼠膀胱癌发生
Gan. 1981 Oct;72(5):647-54.
7
The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.砷与N-丁基-N-(4-羟基丁基)亚硝胺对小鼠膀胱上皮癌发生的相互作用。
PLoS One. 2017 Oct 10;12(10):e0186214. doi: 10.1371/journal.pone.0186214. eCollection 2017.
8
Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].关于“N-丁基-N-(4-羟丁基)亚硝胺诱导的组织特异性诱变作为尿路上皮细胞癌发生的基础”的评论。何Z、科辛斯卡W、赵ZL、吴XR、古滕普兰JB,美国纽约大学牙科学院基础科学系。:《突变研究》2012年;742(1 - 2):92 - 5 [2011年12月4日在线发表]
Urol Oncol. 2014 Feb;32(2):214. doi: 10.1016/j.urolonc.2013.08.014.
9
The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.BBN 诱导的小鼠膀胱癌发生过程中炎症反应的动力学。
J Transl Med. 2019 Nov 28;17(1):394. doi: 10.1186/s12967-019-02146-5.
10
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.水飞蓟素和水飞蓟宾对N-丁基-N-(4-羟基丁基)亚硝胺诱导的雄性ICR小鼠膀胱癌发生的化学预防作用。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55. doi: 10.1158/1535-7163.MCT-07-2006.

引用本文的文献

1
Gold Nanoparticle-Enhanced Production of Reactive Oxygen Species for Radiotherapy and Phototherapy.用于放疗和光疗的金纳米颗粒增强活性氧生成
Nanomaterials (Basel). 2025 Feb 19;15(4):317. doi: 10.3390/nano15040317.
2
Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers.纳米医学与生物安全性的临床见解:常见泌尿系统癌症的先进治疗方法
Front Oncol. 2024 Aug 13;14:1438297. doi: 10.3389/fonc.2024.1438297. eCollection 2024.
3
Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer.

本文引用的文献

1
Immune Priming of the Tumor Microenvironment by Radiation.辐射对肿瘤微环境的免疫启动作用
Trends Cancer. 2016 Nov;2(11):638-645. doi: 10.1016/j.trecan.2016.09.007. Epub 2016 Oct 15.
2
Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.肿瘤相关成纤维细胞对癌细胞放射敏感性的影响。
Future Oncol. 2017 Jul;13(17):1537-1550. doi: 10.2217/fon-2017-0054. Epub 2017 Jul 7.
3
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.用于调节肿瘤微环境以改善药物输送和肿瘤治疗的纳米颗粒。
膀胱癌膀胱内小鼠模型中的非侵入性成像模态
Cancers (Basel). 2023 Apr 20;15(8):2381. doi: 10.3390/cancers15082381.
4
Current applications of nanomaterials in urinary system tumors.纳米材料在泌尿系统肿瘤中的当前应用。
Front Bioeng Biotechnol. 2023 Feb 20;11:1111977. doi: 10.3389/fbioe.2023.1111977. eCollection 2023.
5
Antibacterial Therapy by Ag Ions Complexed with Titan Yellow/Congo Red and Albumin during Anticancer Therapy of Urinary Bladder Cancer.载银钛黄/刚果红-白蛋白复合物用于膀胱癌抗癌治疗中的抗菌治疗。
Int J Mol Sci. 2021 Dec 21;23(1):26. doi: 10.3390/ijms23010026.
6
Novel Iodine nanoparticles target vascular mimicry in intracerebral triple negative human MDA-MB-231 breast tumors.新型碘纳米颗粒靶向颅内三阴性人 MDA-MB-231 乳腺癌血管模拟物。
Sci Rep. 2021 Jan 13;11(1):1203. doi: 10.1038/s41598-020-80862-5.
Pharmacol Res. 2017 Dec;126:97-108. doi: 10.1016/j.phrs.2017.05.004. Epub 2017 May 10.
4
Tumor promoting role of anti-tumor macrophages in tumor microenvironment.抗肿瘤巨噬细胞在肿瘤微环境中的促肿瘤作用。
Cell Immunol. 2017 Jun;316:1-10. doi: 10.1016/j.cellimm.2017.04.005. Epub 2017 Apr 13.
5
Dependence of gold nanoparticle radiosensitization on cell geometry.金纳米颗粒增敏作用取决于细胞形态。
Nanoscale. 2017 May 11;9(18):5843-5853. doi: 10.1039/c7nr01024a.
6
Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy.未联合标准同步化疗的放射治疗膀胱癌的临床结果
Anticancer Res. 2016 Oct;36(10):5519-5525. doi: 10.21873/anticanres.11134.
7
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?病理高危肌肉浸润性膀胱癌的辅助放疗:是时候重新考虑了吗?
Transl Androl Urol. 2016 Oct;5(5):702-710. doi: 10.21037/tau.2016.08.18.
8
Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.质子束治疗对肌层浸润性膀胱癌进行三联保膀胱治疗的长期单机构经验。
Jpn J Clin Oncol. 2017 Jan;47(1):67-73. doi: 10.1093/jjco/hyw151. Epub 2016 Oct 13.
9
Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients.老年患者肌肉浸润性膀胱癌的放射治疗
Anticancer Res. 2016 Sep;36(9):4763-9. doi: 10.21873/anticanres.11033.
10
Bladder Preservation for Muscle Invasive Bladder Cancer.肌肉浸润性膀胱癌的膀胱保留术
Bladder Cancer. 2016 Apr 27;2(2):151-163. doi: 10.3233/BLC-150025.